Negative HER-2 by Immunohistochemistry Correlates Strongly with Negative HER-2 Amplification by Fluorescence In Situ Hybridization in Triple Negative Breast Cancers

被引：0
|
作者：
Xian, R. [1 ]
Raghunath, P. [1 ]
Paul, Z. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
307
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [1] Negative HER-2 by Immunohistochemistry Correlates Strongly with Negative HER-2 Amplification by Fluorescence In Situ Hybridization in Triple Negative Breast Cancers
    Xian, R.
    Raghunath, P.
    Paul, Z.
    LABORATORY INVESTIGATION, 2013, 93 : 75A - 76A
  • [2] Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers
    Haas, Susanne
    Gevensleben, Heidrun
    Rabstein, Sylvia
    Harth, Volker
    Pesch, Beate
    Bruening, Thomas
    Justenhoven, Christina
    Brauch, Hiltrud
    Hamann, Ute
    Ko, Yon-Dschun
    Baisch, Christian
    Fischer, Hans-Peter
    Buettner, Reinhard
    ONCOLOGY REPORTS, 2009, 21 (02) : 299 - 304
  • [3] HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
    Press, MF
    Bernstein, L
    Thomas, PA
    Meisner, LF
    Zhou, JY
    Ma, YL
    Hung, G
    Robinson, RA
    Harris, C
    ElNaggar, A
    Slamon, DJ
    Phillips, RN
    Ross, JS
    Wolman, SR
    Flom, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) : 2894 - 2904
  • [4] CLINICAL RELEVANCE OF CIRCULATING HER-2 IN HER-2 NEGATIVE BREAST CANCER PATIENTS
    Neumann, R.
    BREAST, 2013, 22 : S41 - S42
  • [5] Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer
    Cianciulli, AM
    Botti, C
    Coletta, AM
    Buglioni, S
    Marzano, R
    Benevolo, M
    Cione, A
    Mottolese, M
    CANCER GENETICS AND CYTOGENETICS, 2002, 133 (01) : 66 - 71
  • [6] Aberrant miRNAs expressed in HER-2 negative breast cancers patient
    Braicu, Cornelia
    Raduly, Lajos
    Morar-Bolba, Gabriela
    Cojocneanu, Roxana
    Jurj, Ancuta
    Pop, Laura-Ancuta
    Pileczki, Valentina
    Ciocan, Cristina
    Moldovan, Alin
    Irimie, Alexandru
    Eniu, Alexandru
    Achimas-Cadariu, Patriciu
    Paradiso, Angelo
    Berindan-Neagoe, Ioana
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [7] Aberrant miRNAs expressed in HER-2 negative breast cancers patient
    Cornelia Braicu
    Lajos Raduly
    Gabriela Morar-Bolba
    Roxana Cojocneanu
    Ancuta Jurj
    Laura-Ancuta Pop
    Valentina Pileczki
    Cristina Ciocan
    Alin Moldovan
    Alexandru Irimie
    Alexandru Eniu
    Patriciu Achimas-Cadariu
    Angelo Paradiso
    Ioana Berindan-Neagoe
    Journal of Experimental & Clinical Cancer Research, 37
  • [8] Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer
    Lateef, Fouzia
    Jamal, Saba
    Nasir, Surrayya
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (08): : 581 - 585
  • [9] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
    Jacobs, TW
    Gown, AM
    Yaziji, H
    Barnes, MJ
    Schnitt, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1974 - 1982
  • [10] Correlation of HER-2/neu immunohistochemistry with fluorescence in situ hybridization in 3,568 breast cancers.
    Da Silva, MM
    Horten, BC
    Owens, MA
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S68 - S68
12345